Annually repeated influenza vaccination improves humoral responses to several influenza virus strains in healthy elderly

Vaccine

Volumn 15, Issue 12-13, 1997, Pages 1323-1329

  De Bruijn, Iris A ^a   Remarque, Edmond J ^a   Beyer, Walter E Ph ^b   Le Cessie, Saskia ^a   Masurel, Nic ^b   Ligthart, Gerard J ^a,c  

^a LEIDEN UNIVERSITY   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Annual influenza vaccination; HI antibody; SENIEUR elderly

Indexed keywords

HAEMOPHILUS INFLUENZAE VACCINE; INFLUENZA VACCINE;

ADULT; AGED; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; ELDERLY CARE; HAEMOPHILUS INFLUENZAE TYPE A; HEMAGGLUTINATION; HUMAN; HUMAN CELL; HUMAN TISSUE; HUMORAL IMMUNITY; INFLUENZA; PRIORITY JOURNAL; STRAIN DIFFERENCE; VACCINATION;

ADULT; AGE FACTORS; AGED; ANTIBODIES, VIRAL; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; INFLUENZA VACCINES; ORTHOMYXOVIRIDAE; VACCINATION;

EID: 0030983863     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(97)00019-4     Document Type: Article

References (33)

1. Nicholson, K.G., Snacken, R. and Palache, A.M. Influenza immunization policies in Europe and the United States. Vaccine 1995, 13, 365-369.
2. Barker, W.H. and Mullooly, J.P. Influenza vaccination of elderly persons: reduction in pneumonia an influenza hospitalizations and deaths. J. Am. Med. Assoc. 1980, 244, 2547-2549.
3. Patriarca, P.A., Weber, J.A. and Parker, R.A. et al. Efficacy of influenza vaccine in nursing homes: reduction in illness and complications during an influenza A (H3N2) epidemic. J. Am. Med. Assoc. 1985, 253, 1136-1139.
4. Nichol, K.L., Margolis, K.L., Wuorenma, J. and Von Sternberg, T.L. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N. Engl. J. Med. 1994, 331, 778-784.
5. Pyhälä, R., Kumpulainen, V., Alanko, S. and Forsten, T. HI antibody kinetics in adult volunteers immunized repeatedly with inactivated trivalent influenza vaccine in 1990-1992. Vaccine 1994, 12, 947-952.
6. Hoskins, T.W., Davies, J.R., Smith, A.J., Miller, C.L. and Allchin, A. Assessment of inactivated influenza-A vaccine after three outbreaks of influenza-A at Christs's Hospital. Lancet 1979, i, 33-35.
7. Keitel, W.A., Cate, T.R. and Couch, R.B. Efficacy of sequential annual vaccination with inactivated influenza virus vaccine. Am. J. Epidemiol. 1988, 127, 353-364.
8. Gross, P.A., Quinnan, G.V., Weksler, M.E., Setia, U. and Douglas, R.G. Relation of chronic disease and immune response to influenza vaccine in the elderly. Vaccine 1989, 7, 303-308.
9. Howells, C.H.L., Vesselinova-Jenkins, C.K., Evans, A.D. and James, J. Influenza vaccination and mortality from bronchopneumonia in the elderly. Lancet 1975, i, 381-383.
10. Glathe, H., Bigl, S. and Grosche, A. Comparison of humoral immune responses to trivalent influenza split vaccine in young, middle aged and elderly people. Vaccine 1993, 11, 702-705.
11. Hobson, D., Baker, F.A. and Curry, R.L. Effect of influenza vaccines in stimulating antibody in volunteers with prior immunity. Lancet 1973, 155-156
12. Govaert, T.M.E., Sprenger, M.J.W., Dinant, G.J., Aretz, K., Masurel, N. and Knottnerus, J.A. Immune response to influenza vaccination in elderly people. A randomized double blind placebo controlled trial. Vaccine 1994, 12, 1185-1189.
13. Gruber, W.C., Campbell, P.W., Thompson, J.M., Reed, G.W., Roberts, B. and Wright, P.F. Comparison of live attenuated and inactivated influenza vaccines in cystic fibrosis patients and their families: results of a 3-year study. J. Infect. Dis. 1994, 169, 241-247.
14. Powers, R.D., Hayden, F.G., Samuelson, J. and Gwaltney Jr, J.M. Immune response of adults to sequential influenza vaccination. J. Med. Virol. 1984, 14, 169-175.
15. Sprenger, M.J.W., Mulder, P.G.H., Beyer, W.E.P., van Strik, R. and Masurel, N. Impact of influenza on mortality in relation to age and underlying disease, 1967-1989. Int. J. Epidemiol. 1993, 22, 334-340.
16. Barker, W.H. and Mullooly, J.P. Impact of epidemic type A influenza in a defined adult population. Am. J. Epidemiol. 1980, 112, 798-813.
17. Hall, W.N., Goodman, R.A., Noble, G.R., Kendal, A.P. and Steece, R.S. An outbreak of influenza B in an elderly population. J. Infect. Dis. 1981, 144, 297
18. Barker, W.H. and Mullooly, J.P. Pneumonia and influenza deaths during epidemics: implications for prevention. Arch. Intern. Med. 1982, 142, 85-89.
19. Remarque, E.J., Cools, H.J.M., Boere, T.J., van der Klis, R.J., Masurel, N. and Ligthart, G.J. Functional disability and antibody response to influenza vaccine in elderly patients in a Dutch nursing home. Br. Med. J. 1996, 312, 1015-1-15.
20. Wade, A.W., Green-Johnson, J. and Szewczuk, M.R. Functional changes in systemic and mucosal lymphocyte repertoires with age: an update review. Aging: Immunol. Infect. Dis. 1988, 1, 65-97.
21. Remarque, E.J., van Beek, W.C.A. and Ligthart, G.J. et al. Improvement of the immunoglobulin subclass response to influenza vaccine in elderly nursing-home residents by the use of high-dose vaccines. Vaccine 1993, 11, 649-654.
22. Ligthart, G.J., Corberand, J.X. and Hart, R. et al. Admission criteria for immunogerontological studies in man: the SENIEUR protocol. Mech. Ageing Dev. 1984, 28, 47-55.
23. Beyer, W.E.P., Palache, A.M., Baljet, M. and Masurel, N. Antibody induction by influenza vaccines in the elderly: a review of the literature. Vaccine 1989, 7, 385-394.
24. Masurel, N., Ophof, P. and de Jong, P. Antibody respons to immunization with influenza A/USSR/77 (H1N1) virus in young individuals primed or unprimed for A/New Jersey/76 (H1N1) virus. J. Hyg. Camb. 1981, 87, 201-209.
25. Berlin, B.S., McQueen, J.L., Minuse, E. and Davenport, F.M. A method for increasing the sensitivity of the haemagglutination-inhibition test with equine influenza virus. Virology 1963, 21, 665-667.
26. Beyer, W.E.P., Teunissen, M.W.E., Diepersloot, R.J.A. and Masurel, N. Immunogenicity and reactogenicity of two doses of a trivalent influenza split vaccine. An open randomized study in healthy, unprotected, adult volunteers. J. Drugther. Res. 1986, 11, 369
27. Virelizier, J., Allison, A.C. and Schild, G.C. Antibody responses to antigenic determinants of influenza virus haemagglutinin. II. Original antigenic sin: a bone marrow-derived lymphocyte memory phenomenon modulated by thymus derived lymphocytes. J. Exp. Med. 1974, 140, 1571-1578.
28. Francis, T.J. On the doctrine of the original antigenic sin. Proc. Am. Phil. Soc. 1960, 104, 572-578.
29. Webster, R.G., Kasel, J.A., Couch, R.B. and Laver, W.G. Influenza subunit vaccines II. lmmunogenicity and original antigenic sin in humans. J. Infect. Dis. 1976, 134, 48-58.
30. McElhaney, J.E., Meneilly, G.S., Lechelt, K.E., Beattie, B.L. and Bleackley, R.C. Antibody response to whole-virus and split-virus influenza vaccines in successful ageing. Vaccine 1993, 11, 1055-1060.
31. Powers, D.C. and Belshe, R.B. Effect of age on cytotoxic T lymphocyte memory as well as serum and local antibody responses elicited by inactivated influenza virus vaccine. J. Infect. Dis. 1993, 167, 584-592.
32. Palache, A.M., Beyer, W.E.P. and Sprenger, M.J.W, et al. Antibody response after influenza immunization with various vaccine doses: a double-blind, placebo-controlled, multicentre, dose-response study in elderly nursing-home residents and young volunteers. Vaccine 1993, 11, 3-9.
33. Powers, D.C. and Belshe, R.B. Vaccine-induced antibodies to heterologous influenza A H1N1 viruses: effects of aging and 'original antigenic sin'. J. Infect. Dis. 1994, 169, 1125-1129.